Ishita Drugs And Industries (BOM:524400) Cyclically Adjusted Revenue per Share: ₹50.67 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524400 Ishita Drugs And Industries Ltd BOM:524400
71 GF Score
Price ₹72.70
GF Value ₹64.89
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Ishita Drugs And Industries Cyclically Adjusted Revenue per Share?

Ishita Drugs And Industries BOM:524400 -1.76% 71 Cyclically Adjusted Revenue per Share is ₹50.67 as of Jun. 2026. GuruFocus rates BOM:524400 with a GF Score™ of 71/100 and a GF Value™ of ₹64.89 (Modestly Overvalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Ishita Drugs And Industries's adjusted revenue per share for the three months ended in Jun. 2026 was ₹10.519. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₹50.67 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Ishita Drugs And Industries's average Cyclically Adjusted Revenue Growth Rate was 5.90% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 6.30% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 4.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Ishita Drugs And Industries was 6.30% per year. The lowest was 3.20% per year. And the median was 3.80% per year.

As of today (2026-09-01), Ishita Drugs And Industries's current stock price is ₹72.70. Ishita Drugs And Industries's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was ₹50.67. Ishita Drugs And Industries's Cyclically Adjusted PS Ratio of today is 1.43.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Ishita Drugs And Industries was 2.11. The lowest was 0.54. And the median was 1.46.


Ishita Drugs And Industries  (BOM:524400) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Ishita Drugs And Industries's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=72.70/50.67
=1.43

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Ishita Drugs And Industries was 2.11. The lowest was 0.54. And the median was 1.46.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Ishita Drugs And Industries Cyclically Adjusted Revenue per Share Related Terms


Ishita Drugs And Industries Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Ishita Drugs And Industries's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ishita Drugs And Industries Cyclically Adjusted Revenue per Share Chart

Ishita Drugs And Industries Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 41.60 41.23 43.98 46.50 49.55

Ishita Drugs And Industries Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 47.86 48.98 49.34 49.55 50.67

BOM:524400 vs ZTS: Cyclically Adjusted Revenue per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Ishita Drugs And Industries's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ishita Drugs And Industries Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ishita Drugs And Industries's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Ishita Drugs And Industries's Cyclically Adjusted PS Ratio falls into.


BOM:524400
71GF Score
Ishita Drugs And Industries Ltd BOM:524400
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ishita Drugs And Industries Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Ishita Drugs And Industries's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=10.519/167.3573*167.3573
=10.519

Current CPI (Jun. 2026) = 167.3573.

Ishita Drugs And Industries Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 3.056 105.961 4.827
201612 5.627 105.196 8.952
201703 7.332 105.196 11.665
201706 4.802 107.109 7.503
201709 6.391 109.021 9.811
201712 3.859 109.404 5.903
201803 7.986 109.786 12.174
201806 5.872 111.317 8.828
201809 6.812 115.142 9.901
201812 7.761 115.142 11.281
201903 9.879 118.202 13.987
201906 12.972 120.880 17.960
201909 12.074 123.175 16.405
201912 13.340 126.235 17.686
202003 11.309 124.705 15.177
202006 7.706 127.000 10.155
202009 12.688 130.118 16.319
202012 12.839 130.889 16.416
202103 13.378 131.771 16.991
202106 9.764 134.084 12.187
202109 9.778 135.847 12.046
202112 14.539 138.161 17.611
202203 13.251 138.822 15.975
202206 11.299 142.347 13.284
202209 9.477 144.661 10.964
202212 10.751 145.763 12.344
202303 8.838 146.865 10.071
202306 10.339 150.280 11.514
202309 14.645 151.492 16.179
202312 10.772 152.924 11.789
202403 15.057 153.035 16.466
202406 10.065 155.789 10.812
202409 10.921 157.882 11.576
202412 13.893 158.323 14.686
202503 15.212 157.552 16.159
202506 18.044 159.755 18.903
202509 10.278 162.289 10.599
202512 10.489 163.281 10.751
202603 10.161 164.272 10.352
202606 10.519 167.357 10.519

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of ₹50.67 mean?
Ishita Drugs And Industries (BOM:524400) has a Cyclically Adjusted Revenue per Share of ₹50.67 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Ishita Drugs And Industries and its competitors.
Is Ishita Drugs And Industries' Cyclically Adjusted Revenue per Share too high?
Ishita Drugs And Industries' current Cyclically Adjusted Revenue per Share is ₹50.67. Overall, Ishita Drugs And Industries has a GF Score™ of 71/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ishita Drugs And Industries' Cyclically Adjusted Revenue per Share compare to ZTS?
Ishita Drugs And Industries' Cyclically Adjusted Revenue per Share of ₹50.67 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Revenue per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Ishita Drugs And Industries and its competitors. Ishita Drugs And Industries's current Cyclically Adjusted Revenue per Share is ₹50.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ishita Drugs And Industries stock overvalued right now?
Based on GuruFocus' analysis, Ishita Drugs And Industries (BOM:524400) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹64.89, compared to a current price of ₹72.70 — trading 12% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is ₹50.67. Ishita Drugs And Industries' overall GF Score™ is 71/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Ishita Drugs And Industries (BOM:524400), the current Cyclically Adjusted Revenue per Share is ₹50.67 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ishita Drugs And Industries (BOM:524400) Overvalued in 2026?

Based on GuruFocus' analysis, Ishita Drugs And Industries stock appears to be overvalued. The current stock price of ₹72.70 is trading 12% above its estimated GF Value™ of ₹64.89. GuruFocus considers Ishita Drugs And Industries to be Modestly Overvalued.

Key valuation signals for BOM:524400:

  • Cyclically Adjusted Revenue per Share: ₹50.67
  • GF Value™: ₹64.89 vs. price of ₹72.70 (12% above fair value)
  • GF Score™: 71/100 with 5 warning signs

No single metric tells the full story. See the BOM:524400 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ishita Drugs And Industries Business Description

Address C.G. Road, 401, 3rd Eye -II, Opposite Parimal Garden, Ahmedabad, GJ, IND, 380006
Ishita Drugs And Industries Ltd is engaged in the business of manufacturing various APIs and drug intermediates. The company supplies its products to various pharmaceutical companies and is also being exported to various countries across the world. The company has three manufacturing facilities located in the state of Gujarat, two for APIs and drug intermediates at Ahmedabad and Surendranagar, and one for finished pharmaceutical formulations at Mehsana.
71GF Score

Get the complete analysis for BOM:524400

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹72.70
Price
₹64.89
GF Value